Repligen Corporation Common Stock vs SoundHound AI Inc — how do they compare? Repligen Corporation Common Stock trades at $178.86 (market cap $11.14B), while SoundHound AI Inc trades at $4.44 (market cap $2.17B). The key difference: Repligen Corporation Common Stock is far larger — about 5.1× SoundHound AI Inc's market cap, and Repligen Corporation Common Stock is trading nearer its 52-week high, SoundHound AI Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and SoundHound AI Inc for 24 Days on average.
| RGEN | SOUN | |
|---|---|---|
Market Cap | $11.14B | $2.17B |
Volume | 1,259,263 | 16,604,937 |
Sector | Health | Technology |
52-Week High | $194.57 | $21.40 |
52-Week Low | $102.87 | $4.53 |
Typical Hold Time | 0 Days | 24 Days |
Enterprise Value | $11.02B | $1.98B |
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
SoundHound AI (SOUN) trades at $4.88, down 1.81% on the day, with mixed technical signals showing bearish moving averages but bullish oscillators. The company demonstrates strong revenue growth with 2025 revenue of $168.92M and projected 2026 revenue of $203M, though it remains unprofitable with a -67.45% net income margin. Recent developments include expansion into banking AI agents and the OASYS Edge embedded architecture launch, while analyst consensus remains strongly bullish with a $9.33 price target.
SOUN presents a high-risk, high-reward opportunity with significant growth potential in voice AI markets but faces substantial execution risks. The stock offers 91% upside to analyst targets but requires careful monitoring of profitability improvements and competitive positioning. Key risks include persistent losses, integration challenges from acquisitions, and high valuation multiples despite negative earnings.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.
Read more on SOUN →